Back

Explore every episode of the podcast MBA Training Finance

Dive into the complete episode list for MBA Training Finance. Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.

Rows per page:

1–50 of 94

TitlePub. DateDuration
CohnReznick Aldrich deal: partner pay matters more than revenue14 Oct 202600:10:42
What decides whether CohnReznick's private-equity-backed purchase of Aldrich works? The episode argues it is not the $108 million in revenue, which already has three public versions, but the 48 partners: whether they stay, what they are paid after the scrape, and whether the EBITDA created by cutting their pay survives. It also covers the APS structure, cross-selling claims and the separate value of the Aldrich Wealth arm. Listeners learn how to build a partner table, why a 7 to 11 times multiple on scraped EBITDA raises the stakes, how to age WIP against past write-downs, how to set a working-capital peg before busy season, and why AICPA independence rules can cost clients or the deal. 0:00 Why revenue misleads in CPA firm deals 1:21 Private equity and alternative practice structures 2:51 Mapping partners, books and non-solicits 3:56 The partner pay scrape and EBITDA multiples 7:11 WIP, write-downs and the working-capital peg 8:35 AICPA independence rules and private equity
Starbucks Chipotle bid: why shareholders killed the deal13 Oct 202600:09:02
Why did Starbucks break its no-comment policy to deny a Chipotle bid four days after the Financial Times report? The episode argues the market had already voted: a standard takeover premium meant paying about half of Starbucks' market value, synergies were thin, debt would rise to about six times operating profit, and an all-stock deal would cut earnings per share by about a tenth. It also weighs Brian Niccol's Chipotle history and the denial itself. Listeners leave able to read a share price drop as a shareholder vote on a deal, test debt and equity financing against dilution and capital spending, and run a leak test on their biggest deal or capital project. 0:00 Starbucks denies FT Chipotle bid report 2:09 Takeover premium, debt and EPS dilution 3:47 The Brian Niccol bull case 5:15 Chipotle's staff, silence and defence advisers 6:02 Was breaking no-comment policy smart? 7:38 CFO lessons and the deal leak test
30-year Treasury yield at 24-year high: stress test debt at 6%09 Oct 202600:08:28
Oil above $102 pushed the 30-year Treasury yield to 5.683% and the 10-year to 5.342%, levels last seen in 2002. Is the driver Fed repricing, as Bank of America argues, or a term premium driven by US government debt, as JPMorgan argues? The episode leans toward JPMorgan, citing the bear steepener, while treating Thursday's solid 30-year auction as a fragile window. You will be able to explain term premium and credit spread, weigh short versus long funding against your maturity wall, see how higher risk-free rates lift cost of equity, and reprice 24 months of maturities at Pimco's 6% ten-year scenario against your interest coverage covenant. 0:00 Oil above $100 lifts Treasury yields 1:26 Term premium and the bear steepener 2:33 JPMorgan vs Bank of America on causes 3:58 Pimco's 6% ten-year scenario 4:51 Short vs long debt and cost of equity 7:07 Stress test maturities at 6%
Asset life vs debt tenor: SpaceX's $40bn chip deal07 Oct 202600:08:34
Can you fund four-year Nvidia hardware with thirty-year paper and keep an investment-grade rating? SpaceX is trying, with roughly $10bn of bank loans and $30bn of bonds led by Apollo, and the position here is that the structure sells residual value rather than credit. The episode walks through the BBB threshold, the June $25bn deal that drew $90bn of orders then traded near 85 cents with a 2.27 point spread, Michael Burry's $176bn depreciation claim, and the Bank of England's circular arrangements warning. You leave with a three-part test, life, lock and residual, plus the CoreWeave, Meta and Blue Owl precedents, an asset-life ladder to build, and the purchase obligations footnote to check. 0:00 Asset life versus debt tenor mismatch 1:09 Why $10bn loans plus $30bn bonds 2:32 Three claims about chip collateral tested 4:51 Life, lock, residual: the CFO test 6:13 The refinancing bet, costed 7:07 Mid-cap version: covenants and purchase obligations
Schneider Electric's PTC deal: the 42% premium test06 Oct 202600:10:07
Schneider Electric agreed to pay $205 a share in cash for PTC, a 42.3% premium and about $22.6 billion in equity value, and its own shareholders cut roughly 15 billion euros of market value the same day. The position here is that the strategic slide matters less than the financing structure: the price only looks defensible at 13 times 2027 adjusted EBITA once 800 million euros of revenue synergies are counted, and those are the hardest to deliver. You come away able to separate cost from revenue synergies, read a bridge facility and accelerated bookbuild, track net debt to EBITDA against a Category A rating, and tell EPS accretion apart from a return on capital employed that clears WACC. 0:00 The $22.6bn price and 42% premium 1:42 Synergy math: 21x, 17x, 13x EBITA 2:34 Bridge financing and the equity raise 3:58 Leverage, net debt to EBITDA, Category A ratings 5:57 EPS accretion versus ROCE by year five 7:03 PTC's recurring revenue and what to watch
AI debt issuance: what $450bn does to your spreads02 Oct 202600:09:14
Does a Bank of England warning about AI borrowing change anything for a CFO in packaging or healthcare services? The position here is yes, because you borrow in the same pond. The Financial Policy Committee's 25 September record flags opacity and circular arrangements, Morgan Stanley puts AI-related issuance near $450 billion by early September, and JP Morgan sees about $4.1 trillion of debt-financed capex to 2030. You leave able to read the evidence already in prices: SoftBank's 8.625% to 9.75% coupons, hyperscaler ABS at 150 basis points over the five-year Treasury, CLO demand clustering on double-B names, and Goldman's $510 billion capacity counterargument. 0:00 Circular arrangements in AI financing explained 1:35 Sizing AI debt: $450bn and $4.1trn 3:00 Why CLO buckets set your loan pricing 4:03 Hyperscaler ABS spreads widen over Treasuries 5:58 Goldman's capacity argument against the worry 7:37 Repricing your 18-month maturity schedule
AI concentration risk: what it does to bank NPL ratios01 Oct 202600:04:57
KKR's co-CEO flagged overcrowding in AI-related lending, and the question here is whether bank credit dashboards can see it. The position: they cannot. Cost of risk at 30 to 40 basis points and a eurozone NPL ratio near 1.9 percent describe 2023 to 2025 default behaviour, not what happens if AI capital spending disappoints. Coverage ratios only cushion loans already flagged, and IFRS 9 staging models watch borrowers one at a time. You come away knowing how to read cost of risk, NPL ratio, coverage ratio and Stage 1 to Stage 2 migration together, how to treat Moody's and S&P AI-exposure estimates, and how to build a correlated AI capex stress overlay. 0:00 KKR's AI concentration warning explained 0:46 Why cost of risk looks suspiciously calm 1:27 Eurozone NPL ratio as lagging indicator 2:06 Coverage ratio and rating agency AI data 2:51 IFRS 9 staging misses correlated exposure 4:17 Running one correlated AI stress scenario
$100/kWh batteries: where EV break-even math breaks30 Sep 202600:04:52
Does a $100 per kilowatt-hour battery cell price actually make an electric vehicle cost-competitive with petrol? The answer here is no. The $100 figure is a cell-level number, and once housing, cooling, wiring and safety electronics are added, pack cost sits nearer $130 to $140. An automotive finance leader explains why he shelved a mid-size crossover when the pack hit forty percent of the bill of materials. You come away able to rebuild an EV break-even model on real pack cost, test the three assumptions that fail (price premium, volume, residual value), read BloombergNEF cell data as directional, account for falling used EV values after the Hertz Tesla sell-off, and compete on five-year total cost of ownership. 0:00 Why a crossover program got shelved 0:48 Cell price versus pack cost 2:00 Three places EV break-even breaks 2:38 Residual values and lease payments 3:12 LFP cells and sub-$80 packs 3:44 Rebuilding models on total cost of ownership
Buybacks vs dividends: returning an oil price windfall29 Sep 202600:04:34
Oil prices jumped on the back of the Iran war and TotalEnergies raised both its ordinary dividend and its buyback. The question here is not how much cash goes back to shareholders but through which channel. The position taken: a dividend is a permanent promise, a buyback is discretionary, so windfall cash belongs in buybacks while the dividend stays boring and progressive. You come away with a test for overcommitment, the break-even oil price where operating cash flow covers spending plus the dividend, and Total's move toward the low fifties per barrel. Also covered: Shell's comparable position, BP's 2020 payout cut, ExxonMobil's Pioneer purchase, and when buybacks at cycle peaks destroy value. 0:00 TotalEnergies returns its war-price cash 0:38 Dividends are a marriage, buybacks a fling 1:38 Break-even oil price as the safety test 2:06 Mistaking a price spike for a trend 3:14 Buying back shares at cycle peaks 4:02 Return cash through the channel you can switch off
Biobucks: why reversion rights beat headline deal value27 Sep 202600:04:37
What should a biotech CFO actually negotiate in a milestone-based pharma partnership, when the headline number is mostly contingent? The position here is blunt: a 900 million dollar deal with 40 million upfront is aspiration, and with only 5 to 7 percent of oncology drugs entering Phase 1 reaching approval, most of that value should be priced at pennies on the dollar. You walk away able to rebuild deal value using stage by stage transition probabilities, write reversion rights that return the compound and the safety file together, set diligence obligations with minimum annual spend and fixed development dates, and judge an 8 to 15 percent royalty range against a thin upfront. Vertex style clean reversion is the benchmark. 0:00 When a partner walks away mid-trial 0:49 Biobucks: reading the real deal value 1:35 Reversion rights and data return clauses 2:29 Diligence obligations that stop shelving 3:27 What to trade and what to protect 3:53 Rebuilding deal value with transition probabilities
Hurdle rates: why a 19-year-high 10-year breaks them26 Sep 202600:04:36
Consumer sentiment has fallen to a four-month low while the 10-year Treasury yield sits at a 19-year high. The episode asks whether those two readings change the hurdle rates and WACC sitting in your capital plan, and argues they do. The position: a discount rate set in March, when the 10-year was near 4.2 percent against north of 4.9 percent now, can overstate present value on a 10-year cash flow by 15 to 20 percent. You walk away with a trigger rule for rerunning numbers, the reason a Fed cut can coincide with a rising 10-year as it did in late 2024, and why weak University of Michigan sentiment hits both the numerator and the denominator, as seen in Target's cautious guidance. 0:00 Why your March discount rate is stale 0:54 Fed cuts do not lower the 10-year 1:47 Soft sentiment hits cash flows and discount rates 2:48 Annual WACC policy versus a trigger rule 3:57 Monday morning: rerun borderline capital projects
Reversal rate: the AI finance metric CFOs ignore25 Sep 202600:04:51
Bill Gates has asked governments to act on AI risks he believes could cause mass casualties. Does that headline tell a finance chief anything about their own exposure? The position here is no. The biosecurity scenario is real but separate from the failure that will actually embarrass a CFO in 2026: a model quietly auto-approving payments at a scale the old fraud controls were never calibrated for, including a European logistics firm that paid 400,000 euros to an insolvent supplier. You come away able to take apart the AI finance automation budget line into its three parts, defend document ingestion, challenge the autonomous approval band, and replace automation rate with reversal rate plus a circuit breaker on the auto-approved queue. 0:00 Why the Gates biosecurity warning misleads CFOs 0:44 Invoice ingestion: the component that works 1:32 Autonomous approval limits and correlated model errors 2:43 Reversal rate beats automation rate 3:43 What AI automation really saves in AP 4:05 Monday action: check your dashboard metric
Law firm lock-up: cut WIP days before cash runs dry24 Sep 202600:04:36
Why does a firm post record revenue and still struggle to fund bonuses? The answer is lock-up, the combination of unbilled work in progress and unpaid debtors, expressed in days. The position here is blunt: lock-up is a structural financial risk, not a billing admin chore, and at 110 to 130 days a typical UK firm is making an interest free loan to its own clients funded by an overdraft that costs real money. You walk away able to age WIP into 30, 60 and 90 plus day buckets, calculate lock-up days from daily revenue, price excess days against a borrowing rate near 6 percent, track realisation on fresh versus stale time, and publish lock-up days by partner name. 0:00 Record revenue, zero cash in the bank 0:41 What lock-up is: WIP plus debtors 1:47 Ageing work in progress by bucket 2:42 Costing excess lock-up days in interest 3:15 Making fee earners own lock-up days 3:57 The Monday morning stale WIP email
Hurdle rates: repricing after the 10-year yield jump23 Sep 202600:04:42
Treasury yields moved roughly 90 basis points and most hurdle rates stayed where they were set in 2023. The argument here is that a hurdle rate is a living price tied to the risk free rate, and refusing to move it is fear dressed up as discipline. Two failure modes get named: the frozen rate crowd approving projects against an old 8% bar, and over-correctors who jump to 14% after one bad session. You leave with a way to rebuild weighted average cost of capital from the current 10-year near 4.6%, an equity risk premium of 4 to 5 points and your real debt to equity mix, plus Danaher's quarterly reset practice and a 50 basis point trigger rule. 0:00 Why yields moved and hurdle rates didn't 0:41 Fear dressed as discipline in investment committees 1:27 Danaher's quarterly resets and frozen-rate failures 2:22 Building a 9 to 10% cost of capital 3:05 A 50 basis point reset trigger 3:36 Anaplan, Pigment and the human discount rate call
Airtel Money IPO: what an $8bn floor demands of CFOs22 Sep 202600:04:41
Airtel Money is preparing to file in London for around $800mn in proceeds at an $8bn to $9bn valuation. The question is what that preparation actually requires from a finance chief, and the answer here is blunt: the prospectus is a legal statement of what the business is, not a pitch, and disclosure quality is what moves pricing toward the top of the range. You come away able to read a valuation spread as investor uncertainty, judge whether a price floor is credible or just wishful, test your month end close against listed company timelines, and weigh a thin free float against index eligibility and day 90 trading. 0:00 Why a prospectus is a public promise 0:37 What the $8bn to $9bn spread signals 1:24 When an IPO price floor is credible 2:07 Closing books across 14 African markets 3:12 Free float, liquidity and index access
NATS outage hotel losses: why no one reimburses rooms21 Sep 202600:04:49
When air traffic control fails, as it did at Prestwick in September 2026, who pays for the hotel rooms that go unsold? The answer is the hotel. UK 261 obliges airlines to care for and rebook the passenger, not the property the passenger never reached, and a NATS failure counts as extraordinary circumstances, so even the passenger's compensation shrinks. Business interruption policies rarely help because most wordings require physical damage, a point the COVID litigation settled for insurers. You leave with a way to price the risk rather than transfer it: understand flow-through of 50 to 70 pence in the pound, read the 2023 outage figures, and use flexible rates priced 10 to 15 percent above non-refundable ones to turn cancellations into shifted bookings. 0:00 Why empty hotel rooms are perishable inventory 0:45 UK 261 pays passengers, not hotels 1:46 Flow-through and the 2023 NATS outage 2:49 Business interruption cover needs physical damage 3:32 Pricing flexible rates instead of transferring risk 4:14 Monday action: check non-refundable revenue split
Share buybacks: Buffett's price rule, not a schedule20 Sep 202600:04:45
Greg Abel's appointment as Berkshire Hathaway chairman brought a wave of commentary on Warren Buffett's buyback record. This episode argues the common reading is backwards. Buffett was not a great buyer of his own stock, he was a disciplined refuser, and the discipline lived in a price rule: no repurchases before 2011, then a 1.2 times book value ceiling, then a valuation test that produced about $27 billion of buybacks in 2021 and zero for three straight quarters in the second half of 2024. You leave able to separate the mechanics of a repurchase from its value, read earnings per share against buyback yield and treasury bill returns, weigh the empire building counter argument, and set a written price above which you will not buy a single share. 0:00 Buffett's exit and the buyback myth 0:30 What a share buyback actually does 1:11 Berkshire's 1.2 times book value rule 2:01 Zero buybacks with $300 billion cash 2:45 Why earnings per share hides overpayment 3:34 Write a hard price rule for buybacks
Earnouts: the discount rate CFOs forget to negotiate19 Sep 202600:04:48
Can an earnout really bridge a valuation gap when rates keep moving? The position here is that most earnouts are a disagreement both sides agreed to postpone, and the discount rate is where the two views collide. A 10 million payout three years out was worth about 9 million at a 3% discount in 2021, and roughly 7.5 million at 8 to 9% today, with no change to the target. You come away knowing how contingent consideration sits as a balance sheet liability, why quarterly remeasurement pushes gains and losses through earnings, and the three conditions for a workable earnout: an ungameable metric like gross profit, a window of two years maximum, and discount treatment fixed in the contract. Examples include pharma contingent value rights, the AbbVie Cerevel deal, and Microsoft's preference for short binary triggers. 0:00 Why most earnouts hide a disagreement 0:39 The discount rate problem in contingent consideration 1:55 Pharma CVRs and quarterly remeasurement swings 2:58 Three conditions where earnouts actually work 3:31 Fixed nominal payouts and short windows 4:14 Monday morning check on open earnouts
Trapped capital: what Russia's Nestlé seizure means for CFOs18 Sep 202600:04:49
Russia's forced transfer of Nestlé and Auchan operations is the first since 2023, and the question here is why enterprise risk models keep mispricing it. The position: the error is not missing the geopolitical risk but modelling asset seizure as one binary write-off, when the real mechanism is external management by a Kremlin appointed administrator, blocked dividends and write-downs that arrive in waves, as Danone and Carlsberg's Baltica Brewery showed. Listeners get a working metric, the repatriation ratio, meaning the share of subsidiary earnings that can legally leave the country, plus a test for political risk analytics tools from Verisk and Kroll, and a ring-fencing structure that keeps local cash away from parent covenants. 0:00 Russia seizes Nestlé and Auchan operations 0:35 Trapped capital: assets you own but cannot touch 1:07 External management and years of accounting limbo 2:19 The repatriation ratio CFOs should track 2:55 Political risk vendors and ring-fencing subsidiaries 4:02 Marking down trapped cash on Monday
Dual listings: why Revolut inherits the bank discount17 Sep 202600:04:39
Revolut is preparing to list in both New York and London, and most people read that as a smart hedge on access to capital. This episode argues the opposite: a dual listing is a signal that no single market bought the equity story, and the two prices reconcile through arbitrage at the lower conviction of the two investor crowds, leaving a tech ambition priced on bank logic near seven times earnings. You come away able to build an equity story around a chosen comparison set rather than an exchange, using Wise's London-only 2021 direct listing as the counterexample, and able to restate headline customer counts as funded active users before investors do it for you. 0:00 Why a dual listing is a confession 0:52 Tech multiples versus bank multiples 1:33 Arbitrage pulls you to the lower price 1:57 Index inclusion and regulatory goodwill 2:23 Pick your comparison set, Wise example 3:06 Customer counts and funded active users
Content library valuation: what media CFOs get wrong16 Sep 202600:04:46
Media companies call their content libraries their biggest asset, but the balance sheet shows capitalized production cost less amortization, which says nothing about what the titles earn. The position here is blunt: a show that cost 40 million and earns nothing carries the same way as one that cost 10 million and prints cash, so cost-based carrying value is close to meaningless. You come away able to build a discounted cash flow model per title or cluster, apply a decay curve to post-release revenue, and test for the three failure points: catalog versus new releases, rights expiry by territory, and platform dependency on a single output deal. The Clearlake-Chelsea structure shows how contracted rights earn a lower discount rate, and the Warner Bros. Discovery and Paramount impairments show what happens when they do not. 0:00 Why content libraries sit at cost 1:02 Building a per-title cash flow model 2:10 Three places library valuation breaks down 2:47 What the Clearlake-Chelsea deal revealed 3:36 Streaming write-downs and proving durability
Fee compression: active management is not dying15 Sep 202600:04:58
Passive flows into index funds and ETFs have dominated the last decade, and most people read that as the end of active management. The position here is different: the market did not kill a category, it killed a price point. What died was the commodity middle, large cap US equity charging 80 basis points for benchmark hugging, while scarcity based strategies like private credit, emerging market debt and small caps kept growing fee related earnings at firms such as Apollo and Ares. You leave with a sorting test for every product line, access or outcome, a warning about crowding into private credit as fees drift from 1.5% toward 1%, and the Morgan Stanley case for owning the relationship through Eaton Vance and E-Trade. 0:00 Why passive flows killed closet indexing 0:46 The commodity middle lost the price point 1:09 Where active still earns fees: private credit, EM debt 2:12 Secular versus cyclical: the CFO misread 3:09 Access or outcome: the fee stickiness test 4:06 Margin moves to distribution and advice
Hurdle rates after a Warsh hike: what CFOs reprice14 Sep 202600:04:53
Kevin Warsh refused to rule out a rate increase with inflation above the 2% target and oil above $100, and the two-year Treasury yield moved about 20 basis points in a session. The position here is blunt: CFOs who built 2026 rate cuts into a single base case treated a forecast as a fact, and the arithmetic of refinancing at 7% instead of 5% costs a billion dollar balance sheet roughly $20 million a year. You walk away able to rerun your capital budget at a higher discount rate, pressure test acquisitions and capex that depend on financing, check interest coverage covenants for a breach caused by rates alone, and price tariff uncertainty into your risk premium. 0:00 Warsh signals another rate hike 0:52 How 20 basis points moves hurdle rates 1:38 Stress testing plans for rates up 100bps 2:25 Interest coverage covenants and leveraged buyouts 3:17 Fed credibility, tariffs and risk premium 4:10 Rerun your biggest decision at plus 150bps
Captive finance arms: residual value risk when rates stay high13 Sep 202600:04:47
Why do Ford, Toyota and GM each run a lender inside the company, and what happens to that structure when rate cuts stop coming? The position here is that captive finance arms such as Ford Credit, Toyota Financial Services and GM Financial are sales tools first: 0% for 60 months is a price cut moved into the financing, and securitization keeps the borrowing at the subsidiary so the parent keeps its investment-grade rating. You leave able to explain how lease residual values are set, how a wrong residual turns into a per-vehicle loss at auction, and how hot core CPI in September 2026 squeezes funding spreads and used prices at once. The practical step is checking assumed lease-end values against the Mannheim used vehicle index. 0:00 The bank hidden inside every automaker 0:36 What a captive finance arm does 1:22 Securitization and the parent's credit rating 2:05 How residual value assumptions go wrong 3:05 Hot core CPI squeezes spreads and residuals 3:52 Tracking the residual-to-market gap
Tata Sons forced listing: IPO planning lessons for CFOs13 Sep 202600:04:51
The Reserve Bank of India rejected Tata Sons' appeal against mandatory listing, and most coverage reads it as governance. The position here is different: it is a forecasting story. A holding company sitting above Tata Consultancy Services, Air India and dozens of others cannot present a consolidated mood board once outside analysts price the parent's own cash flows. You walk away able to run two forecasts in parallel, an operational plan and a listable view that strips out related party revenue, and to test whether your intercompany dividend policy is defensible. The episode uses WeWork's fall from roughly $47bn after community adjusted numbers were recomputed, and explains why Anaplan and Workday Adaptive Planning fix speed, not judgment. 0:00 Tata Sons forced listing as forecasting story 1:10 IPO planning starts three years early 1:40 Intercompany dividends and holding company cash flow 2:47 Building the listable view forecast 3:36 Do Anaplan and Adaptive Planning help
Risk-adjusted NPV: how to value pre-revenue biotech11 Sep 202600:05:02
How do you put a defensible number on a drug candidate that has never sold a dollar and may never reach a patient? The answer is risk-adjusted NPV, which haircuts projected peak sales by the cumulative probability of success at each clinical stage. This episode walks through the mechanics and argues the math is sound while the inputs are where it quietly fails. You come away knowing the BIO likelihood-of-approval benchmarks, roughly one in ten from phase one and closer to 5% in oncology, why 15 to 20% discount rates beat the standard 10 to 12%, how Alzheimer's programs fell 80% on readout, and why vendor defaults from Alacrita or Evaluate are averages your drug is not. 0:00 Valuing a biotech with no revenue 0:44 How risk-adjusted NPV mechanics work 1:42 Why the inputs break the model 2:14 Discount rates for pre-revenue biotech 2:48 Alzheimer's trials and 80% drawdowns 3:36 Vendor benchmarks and sensitivity tables
Zero-based budgeting: what it really demands from a CFO10 Sep 202600:04:47
Zero-based budgeting is sold as a cost-cutting trick, and that framing is what keeps failing. The episode argues ZBB is about knowing what you are buying, not spending less, and contrasts it with incremental budgeting, the last year plus 3 percent habit that protects decisions nobody remembers making. The Kraft Heinz and 3G Capital story, from the 2015 rollout to the 2019 $15 billion write-down, is used as the warning, while Unilever's find of duplicate analytics tooling shows where the money actually sits. Listeners leave knowing which categories to zero-base, software, travel, consulting, agencies and facilities, which to leave alone, how long a first pass takes, and why a ZBB template in a planning tool is not a decision. 0:00 Why zero-based budgeting keeps coming back 0:38 Kraft Heinz, 3G Capital and the $15bn write-down 1:27 Incremental budgeting and the plus 3 percent default 2:16 Where ZBB earns its keep and where it wastes time 3:05 Cycle length, cost owners and planning software limits 3:59 Monday morning: one category, one owner
Belron's IPO: what mega-listing readiness demands09 Sep 202600:04:43
Belron repairs car glass through Safelite and Carglass, carries roughly 6 billion dollars of revenue, and is now reported to be weighing a mega-listing. The question here is what actually has to be true before a business of that size can go public, and the answer is three years of audited numbers, a story that survives a hostile hedge fund, and management that holds up under quarterly scrutiny. You come away able to read the primary and secondary split in an offer, to test a margin story against the Ferrari 2015 and Aston Martin 2018 precedents, to name the roles on a deal team from lead underwriters to the independent advisor and investor relations, and to start rehearsing quarterly close a year early. 0:00 Why Belron's windscreen business attracts bankers 0:43 Three conditions before any IPO 1:24 Primary versus secondary share split 1:54 Ferrari 2015 versus Aston Martin 2018 2:56 Who sits on the IPO deal team 3:51 Reporting like a public company early
Elliott at Honeywell: run the short thesis on yourself08 Sep 202600:04:51
Can a finance chief stay ahead of an activist fund that can read every 10-K, transcript and segment disclosure through a language model in minutes? The position here is that the speed has changed, not the analysis, and the CFO who has already run the attack on their own company has nothing to fear. The Elliott Management stake in Honeywell in late 2024 and the three-way split announced in February 2025 are used as the test case. You come away with a method: build a sum-of-the-parts valuation, name your three weakest segments, model a tax-efficient separation, and put that memo in front of your board first. 0:00 How AI lets funds read your filings first 0:49 Elliott's $5 billion Honeywell stake and the three-way split 1:33 Writing the short thesis on your own company 2:35 What an unprepared board loses: narrative, seats, timing 3:41 Small caps can no longer hide in obscurity
Sell-through curves: pricing markdown risk early07 Sep 202600:04:38
Panama Canal transit caps and Red Sea reroutes from the Iran conflict are adding 10 to 14 days per container and pushing landed costs up double digits, so fall apparel lands in October instead of August. The question is what a CFO does when the reorder and chase window has closed and the only remaining lever is price. The position here: read sell-through against a curve, not a flat weekly target, and recognize the markdown when the signal appears. You walk away with a 15 point trailing rule at the one third mark of the selling window, a method for sizing a markdown reserve at 30 to 50 percent discount depth, guidance on holding ticket price on fashion while conceding on basics, and a view on Inditex short cycles and AI markdown tools. 0:00 Panama Canal delays hit fall inventory 0:24 How much margin the reroutes cost 1:16 Reading sell-through against the curve 2:12 Booking a markdown reserve early 3:13 Passing freight costs to customers 4:06 Monday morning action on fall styles
Liquidity ladder: what CFOs can actually spend today06 Sep 202600:04:46
Cash on the balance sheet and liquidity are different numbers, and the gap is where treasury teams get caught when credit tightens. The position here is blunt: reported cash flatters you, and the panic drawdown of a revolving credit line is a lazy, expensive answer. One mid market manufacturer reported 40 million in cash and equivalents in early 2026 and had about 14 million genuinely spendable, with money trapped behind Brazilian currency controls, parked in a seven day money market fund, and reserved for a covenant test. You come away able to build a liquidity ladder sorted by days to access, read your MAC clause and leverage triggers before you need the money, add receivables facilities, supply chain finance and private credit lenders alongside relationship banks, and run a 13 week cash forecast that shows the daily low point. 0:00 Why cash is king misleads treasury teams 0:38 40 million on paper, 14 million reachable 1:27 Revolver drawdowns and the MAC clause 2:58 Diversifying beyond two relationship banks 3:33 Forecasting the intramonth trough, not the average 4:11 The one liquidity question to answer tomorrow
Equity story: why momentum isn't structural advantage05 Sep 202600:04:41
Why do equity stories fail when the underlying business is fine? The position here is that most executives write a recap of three good quarters instead of a claim about the future, confusing momentum with structural advantage. Peloton in 2020 is the cautionary case: a story built on everyone staying home, followed by a fall of more than 90%. You walk away with a way to build the narrative in one sentence covering who pays you, why they cannot easily stop, and why it improves with scale. It covers falsifiable claims, net revenue retention above 120% and Snowflake's 158% at IPO, gross margin honesty, Amazon preempting the profit question, and checking definitions behind tools like Gainsight. 0:00 Why most equity stories fail 0:39 Momentum versus structural advantage: the Peloton case 1:35 Three falsifiable claims and net revenue retention 2:29 Naming gross margin weakness before investors do 3:16 Freeze acquisition: treadmill or franchise test 4:03 Pressure test your story with a skeptical board member
xP&A at Unilever: one forecast, three functions04 Sep 202600:04:49
Can a business the size of Unilever really run one plan? The episode answers by tracing how finance, sales and supply chain each built their own forecast, a revenue plan, a demand plan and a volume plan that never reconciled until the quarter closed. The position taken is blunt: integrated planning is a governance outcome, not a technology purchase, and extended planning and analysis works only when one set of numbers is argued over in a shared model. Listeners get a way to test their own planning architecture: lay the revenue, demand and supply volume numbers side by side, check the gap, see where working capital and stranded stock leak, and decide who owns assumptions versus reconciliation. 0:00 Three planning silos inside Unilever 1:05 What xP&A actually means in practice 2:01 Who owns the master forecast number 2:31 Working capital cost of forecast error 3:55 Rebuild timeline and the Monday test
Commercial paper risk: Chrysler's 2008 liquidity lesson03 Sep 202600:04:51
What happens when a company funds long-term needs with paper that matures in 30 days and the market stops buying? Using Chrysler's October 2008 experience after the Lehman Brothers collapse and money market funds breaking the buck, the episode argues the failure was concentration, not carelessness. Committed bank credit lines looked like a backstop until every issuer drew at once, rating agencies took notice, and banks such as Washington Mutual failed. You come away with a way to test your own position: run a liquidity stress test that assumes your short-term funding market closes and a backstop bank cannot fund, then find the single worst week in your maturity schedule and cover it with cash you control. 0:00 When Chrysler's commercial paper market vanished 0:52 Why rollover risk was treated as theoretical 1:24 Drawing the revolver and its warning signals 2:24 Diversify funding and stagger maturities 3:16 Silicon Valley Bank repeats the 2008 mistake 3:49 The two-failure liquidity stress test
Carve-out valuation: the allocated cost trap CFOs miss02 Sep 202600:04:47
Can you value a divested division from the financial statements the seller hands you? The position here is no. A carve-out is a business that never operated alone, and its statements allocate shared costs such as legal, IT and the CEO's salary by formula rather than showing what the unit costs to run. Examples include GE's healthcare unit and Dell's 2021 sale of Boomi. You come away able to test a carve-out price properly: strip every allocated cost line, build a standalone operating model function by function, check transition services agreement pricing and lock-in terms, budget 3 to 5 percent of revenue for one-time separation spend, and price dis-synergies before bidding. 0:00 Why carve-out financials are a fiction 1:09 Allocated overhead versus true standalone cost 1:50 Transition services agreements priced to hurt 2:54 One-time separation costs after close 3:40 Pricing dis-synergies instead of assuming synergy 4:10 Rebuild every function from zero
Dynamic discounting vs supply chain finance: which to use01 Sep 202600:04:34
Should a finance team rent the bank's balance sheet or use its own cash to pay suppliers early? This episode separates supply chain finance, also called reverse factoring, from dynamic discounting, and argues most CFOs confuse the two. Supply chain finance prices a supplier discount off the buyer's credit rating and can quietly become undisclosed debt, as it did at Carillion, which stretched payments to 120 days before collapsing in 2018, and at Abengoa. You finish able to tell which tool fits your cash position, price a 2% discount for 20 days early as a return above 36% against a 4% treasury deposit, check days payable outstanding and idle cash, and pilot discounting on your top 50 suppliers. 0:00 Cash trapped in your payment terms 0:36 How reverse factoring actually works 1:20 Carillion, Abengoa and hidden debt 2:00 Dynamic discounting explained 2:35 The 36% annualised return on early payment 3:54 Running a pilot on 50 suppliers
Scenario planning under real uncertainty: a CFO playbook30 Aug 202600:04:41
Most scenario planning exercises produce tidy three-scenario decks that comfort boards and mislead decision-makers. This playbook shows how to build scenarios that actually change what your company does.
Working capital optimization as a source of strategic liquidity: a CFO playbook29 Aug 202600:04:37
Most CFOs sit on a significant cash reserve they have not yet recognized: the working capital trapped in their own operations. This playbook shows how to extract it systematically, without touching the credit facility or the dividend.
The cash hiding in plain sight: how Procter & Gamble turned its supply chain into a weapon28 Aug 202600:04:50
In 2012, P&G faced mounting pressure from activist investor Bill Ackman and a restless shareholder base demanding proof that management could extract more value from its sprawling operations. The answer came not from a dramatic acquisition or a bold restructuring, but from renegotiating payment terms with suppliers, and it changed how CFOs think about working capital permanently.
How Unilever rebuilt its forecasting on drivers, not budgets27 Aug 202600:04:42
Unilever's finance function spent years trapped in a cycle of annual budgets that were outdated before the ink dried. Its move to driver-based, rolling forecasts offers a detailed blueprint for CFOs who want forecasts that actually inform decisions.
IPO readiness and what it really takes25 Aug 202600:04:46
Getting a company to IPO is not primarily a banking exercise. It is an organizational transformation that most CFOs underestimate until they are already inside it.
Zero-based budgeting revisited: what still works and what doesn't24 Aug 202600:04:32
Zero-based budgeting promised to eliminate waste and force accountability into every dollar spent. After decades of boom-and-bust adoption cycles, CFOs in 2026 have enough evidence to make a clear-eyed judgment about when it delivers and when it quietly destroys value.
Modernizing the finance ERP and data core: a CFO's execution playbook23 Aug 202600:04:31
Most finance ERP modernization projects stall not because the technology fails, but because the sequencing is wrong and the data governance is an afterthought. This playbook gives CFOs a concrete, ordered set of moves to replace legacy infrastructure without breaking the close cycle or burning two years of goodwill.
Managing activist investors: a CFO's step-by-step playbook22 Aug 202600:04:44
Activist campaigns move fast, and an unprepared CFO hands activists the narrative before the first public letter lands. This playbook gives you a concrete sequence to build defenses, engage constructively, and protect long-term value without losing the board's confidence.
CSRD reporting: from scramble to system20 Aug 202600:04:46
Most finance teams entering their first CSRD reporting cycle are still stitching together data from spreadsheets, sustainability teams, and supplier emails. This playbook walks CFOs through the steps to build a repeatable, audit-ready process before the next deadline hits.
Hedging FX and rate risk without gambling: what the consensus gets wrong18 Aug 202600:04:45
Most treasury teams treat derivatives as insurance policies and stop there. The real discipline is knowing which exposures are worth hedging at all, and at what cost to the business.
How Unilever rebuilt its budgeting process using zero-based principles17 Aug 202600:04:49
Unilever's adoption of zero-based budgeting starting in 2016 forced every cost line to earn its place each year rather than inherit it from the prior period. The mechanics, the results, and the limits of that approach carry concrete lessons for any CFO weighing a similar reset.
Pricing climate risk into capital allocation: a CFO's playbook16 Aug 202600:04:49
Climate risk is no longer a qualitative footnote in investment memos. This playbook shows CFOs how to quantify it, embed it in capital allocation processes, and avoid the analytical traps that make most attempts fall short.
The hidden drain: how M&A integration became the graveyard of deal value15 Aug 202600:04:31
Most M&A deals look good on paper right up until the moment they don't. The story of how practitioners learned where value actually disappears during integration is stranger, and more instructive, than the standard deal-room mythology suggests.
The capital stack decision: how CFOs structure deal financing to control risk and return14 Aug 202600:04:45
How you layer debt, equity, and hybrid instruments in an acquisition shapes every downstream outcome, from cash flow flexibility to return on equity. This article breaks down the mechanics of capital stack construction and the tradeoffs CFOs must weigh before a deal closes.
© My Podcast Data · Independent project · Data from Apple & Spotify